Advertisement

Quality of Life in Amenorrhea and Oligomenorrhea

  • William W K To
Reference work entry

Abstract:

 Oligomenorrhea and  amenorrhea are common forms of menstrual dysfunction that occurs in reproductive age group women. The clinical implications of such menstrual disturbance will depend on the specific diagnosis and on the presence or absence of associated problems, such as infertility or other hormonal or metabolic disturbances. Little attention has been paid in the past to the psychological impact of these symptoms and their effect on the women’s perceived  quality of life (QOL). Current available literature on the QOL associated with amenorrhea and oligomenorrhea has largely focused on specific conditions such as  Turner syndrome,  premature ovarian failure, or  polycystic ovarian syndrome, while many other common and uncommon conditions have not yet been evaluated in detail. In addition, disease specific questionnaires have only been validated for conditions such as polycystic ovarian disease and eating disorders, but not for menstrual dysfunction in general, so that most studies have relied on generic survey tools such as the SF-36. The current available literature showed that oligomenorrhea and amenorrhea resulting from various conditions does have demonstrable negative effects on the perceived QOL of affected women. Such negative effects are most significant in women with associated infertility, metabolic disturbances such as obesity and hyperandrogenism and other medical problems. In women with relatively mild degree of menstrual disturbance with oligomenorrhea, the impact on quality of life largely depends on their interpretation and acceptance of the symptoms.

Keywords

Eating Disorder Turner Syndrome Premature Ovarian Failure Growth Hormone Therapy PCOS Woman 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:

FSH

follicular stimulating hormone

GnRH

gonadotrophin releasing hormone

LH

luteinizing hormone

PCOS

polycystic ovarian syndrome

POF

premature ovarian failure

QOL

quality of life

SF-36

short form 36

TS

Turner syndrome

References

  1. Balen AH, Shoham Z, Jacobs HS. (1993). In: Asch RH and Studd JJW (eds.) Annual Progress in Reproductive Medicine. Parthenon Press, Carnforth, Lancashire, pp. 205–234.Google Scholar
  2. Bannink EM, Raat H, Mulder PG, de Muinck Keizer-Schrama SM. (2006). J Pediatr. 48: 95–101.Google Scholar
  3. Boughton MA. (2002). J Adv Nurs. 37: 423–430.PubMedCrossRefGoogle Scholar
  4. Cardoso G, Daly R, Haq NA, Hanton L, Rubinow DR, Bondy CA, Schmidt P. (2004). Gynecol Endocrinol 19: 313–319.PubMedGoogle Scholar
  5. Carel JC, Ecosse E, Bastie-Sigeac I, Cabrol S, Tauber M, Leger J, Nicolino M, Brauner R, Chaussain JL, Coste J. (2005). J Endocrinol Metab. 90: 1992–1997.CrossRefGoogle Scholar
  6. Carel JC, Elie C, Ecosse E, Tauber M, Leger J, Cabrol S, Nicolino M, Brauner R, Chaussain JL, Coste J. (2006). J Clin Endocrinol Metab. 91: 2972–2979.PubMedCrossRefGoogle Scholar
  7. Ching HL, Burke V, Stuckey BGA. (2007). Clin Endocrinol. 66: 373–379.CrossRefGoogle Scholar
  8. Choi PY, McKeown S. (1997). J Psychoso Obstet Gynecol. 18: 259–265.CrossRefGoogle Scholar
  9. Coffey S, Mason H. (2003). Gynecol Endocrinol. 17: 379.PubMedCrossRefGoogle Scholar
  10. Conway GS. (2002). Baillieres Best Pract Res Clin Endocrinol Metab. 16: 243–261.CrossRefGoogle Scholar
  11. Coulam CB, Adamson SC, Annegers JF. (1986). Obstet Gynecol. 67: 604–606.PubMedGoogle Scholar
  12. Critchley HOD. (2003). In: Shaw RW, Soutter WP, Stanton SL (ed.) Gynaecology, 3rd ed. Churchill Livingstone, London, pp. 229–244.Google Scholar
  13. DeSouza MJ, Williams NI. (2004). Hum Reprod Update. 10: 433–438.CrossRefGoogle Scholar
  14. De Taraciuk MB, Nolting M, Fernandez G, Colela D, Onetto C, Straminsky V. (2008). Gynecol Endocrinol. 24: 44–53.PubMedCrossRefGoogle Scholar
  15. Elsenbruch S, Hahn Kowalsky D, Offner AH, Schedlowski M, Mann K, Janssen OE. (2003). J Clin Endocrinol Metab. 88: 5801–5807.PubMedCrossRefGoogle Scholar
  16. Groff AA, Covingtom SN, Halverson LR, Fitzgerald OR, Vanderhoof V, Calis K, Nelson LM. (2005). Fert Steril. 83: 1734–1741.CrossRefGoogle Scholar
  17. Guyatt G, Weaver B, Cronin L, Dooley JA, Azziz R. (2004). J Clin Epidemiol. 51: 1279.CrossRefGoogle Scholar
  18. Habelt K, Brosche T, Riedel HH. (1996). Zentralbl Gynakol. 118: 206–212.PubMedGoogle Scholar
  19. Hahn S, Benson S, Elsenbruch S, Pleger K, Tan S, Mann K, Schedlowski M, van Halteren WB, Kimmig R, Janssen OE. (2006). Human Reprod. 21: 1925–1934.CrossRefGoogle Scholar
  20. Harlow SD, Ephross SA. (1995). Epidemiologic Rev. 17: 256–286.Google Scholar
  21. Hull KL, Harvey S. (2003). J Endocrinol. 179: 311–333.PubMedCrossRefGoogle Scholar
  22. Janssen OE, Hahn S, Tan S, Benson S, Elsenbruch S. (2008). Semin Reprod Med. 26: 45–52.PubMedCrossRefGoogle Scholar
  23. Kadir RA, Sabin CA, Pollard D, Lee CA, Economides DL. (1998). Haemophilia. 4: 836–41.PubMedCrossRefGoogle Scholar
  24. Khastgir G, Studd J. (1999). Menopause. 6: 180–181.Google Scholar
  25. Kilic BG, Ergur AT, Ocal G. (2005). J Pediatr Endocrinol. 18: 1111–1117.Google Scholar
  26. Liao KL, Wood N, Conway GS. (2000). J Psychosom Obstet Gynaecol. 21: 167–174.PubMedCrossRefGoogle Scholar
  27. Manocchia M, Bayliss MS, Connor J, Keller SD, Shiely JC, Tsai C, Voris RA, Ware JE. (1998). SF-36 Health Survey Annotated Bibliography: Second Edition (1988–1996). The Health Assessment Lab, New England Medical Centre, Boston, MA.Google Scholar
  28. Marcus MD, Loucks TL, Berga SL. (2001). Fert Steril. 76: 310–316.CrossRefGoogle Scholar
  29. McCook JG, Reame NE, Thatcher SS. (2005). J Obstet Gynecol Neonatal Nurs. 34: 12–10.PubMedCrossRefGoogle Scholar
  30. Morgan T. (2007). Am Fam Physician. 76: 405–410.PubMedGoogle Scholar
  31. Okada Y. (1994). J Endocrinol. 41: 345–354.Google Scholar
  32. Orley J, Saxena S, Herman H. (1998). Br J Psychiat. 172: 291–293.CrossRefGoogle Scholar
  33. Pavlidis K, McCauley E, Sybert VP. (1995). Clin Genet. 47: 85–89.PubMedCrossRefGoogle Scholar
  34. Ravaldi C, Vannacci A, Zucchi T, Mannucci E, Cabras PL, Boldrini M, Murciano L, Rotella CM, Ricca V. (2003). Psychopathology. 36: 247–254.PubMedCrossRefGoogle Scholar
  35. Ringham R, Klump K, Kaye W, Stone D, Libman S, Stowe S, Marcus M. (2006). Int J Eat Disord. 39: 503–508.PubMedCrossRefGoogle Scholar
  36. Rotterdam ESHERE/ASRM-sponsored PCOS consensus workshop group. (2004). Human Reprod. 19: 41–43.CrossRefGoogle Scholar
  37. Salbach H, Klinkowski N, Pfeiffer E, Lehmkuhl U, Korte A. (2007). Psychopath. 40: 388–393.CrossRefGoogle Scholar
  38. Schmid J, Kirchengast S, Vytiska-Binstorfer E, Huber J. (2004). Human Reprod. 19: 2251–2257.CrossRefGoogle Scholar
  39. Sutton EJ, McInerney-Leo A, Bondy CA, Gollust SE, King D, Biesecker B. (2005). Am J Med Genet A. 139: 57–66.Google Scholar
  40. Sybert VP, McCauley E. (2004). N Engl J Med. 35: 1227–1238.CrossRefGoogle Scholar
  41. Sylven L, Hagenfeldt K, Brondum-Nielsen K, von-Schoultz B. (1991). Acta Endocrinol. (Copenh) 125: 359–365.Google Scholar
  42. To WWK, Wong MWN. (2007). J Pediatr Adolesc Gynecol. 20: 83–88.PubMedCrossRefGoogle Scholar
  43. To WWK, Wong MWN, Lam IVY. (2000). Acta Obstet Gynecol. 79: 1117–1123.Google Scholar
  44. Ventura JL, Fitzgerald OR, Koziol DE, Covington SN, Vanderhoof VH, Calis KA, Nelson LM. (2007). Fert Steril. 87: 584–590.CrossRefGoogle Scholar
  45. Ware JE, Sherbourne CD. (1992). Med Care. 30: 473–480.PubMedCrossRefGoogle Scholar
  46. World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. (1986). J Adole Health Care. 7: 236–244.CrossRefGoogle Scholar
  47. Yang TM, To WWK. (2006). HK J Gynaecol Obstet Midwif. 6: 24–31.Google Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • William W K To
    • 1
  1. 1.Department of Obstetrics & GynaecologyUnited Christian HospitalKwun TongHong Kong

Personalised recommendations